Skip to main navigation Skip to search Skip to main content

Two neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize the receptor binding domain of the molecule

  • Christopher B. Brown*
  • , Charles E. Hart
  • , Deeann M. Curtis
  • , Mason C. Bailey
  • , Kenneth Kaushansky
  • *Corresponding author for this work
  • University of Washington
  • ZymoGenetics, Inc.

Research output: Contribution to journal › Journal Article › peer-review

44 Scopus citations

Abstract

Using a series of mutant and chimeric human-mouse granulocyte-macrophage-CSF molecules the binding epitopes of two neutralizing mAb antibodies to human GM-CSF have been mapped. Both intact antibody and Fab fragments neutralize the biologic activity of human GM-CSF. The epitope of one of the antibodies contains residues widely separated in the primary structure of the growth factor that suggests that these two regions are adjacent in the tertiary structure of the molecule. In addition, evidence is presented that both mAb neutralize the activity of this cytokine by blocking the receptor binding domain of human GM-CSF.

Original languageEnglish
Pages (from-to)2184-2189
Number of pages6
JournalJournal of Immunology
Volume144
Issue number6
StatePublished - 15 03 1990
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Two neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize the receptor binding domain of the molecule'. Together they form a unique fingerprint.

Cite this